Printer Friendly
The Free Library
14,678,926 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Pentapharm obtains United States patent.


Pentapharm AG (Switzerland) has patented a method for detecting disorders in the protein C system, and in particular for determining the activated activated

a state of being more than usually active. In biological systems this is usually brought about by chemical or electrical means. Commonly said of pharmaceutical and chemical products.
 blood coagulation Noun 1. blood coagulation - a process in which liquid blood is changed into a semisolid mass (a blood clot)
blood clotting

clotting, coagulation, curdling - the process of forming semisolid lumps in a liquid
 factor V with increased stability with respect to decomposition decomposition /de·com·po·si·tion/ (de-kom?pah-zish´un) the separation of compound bodies into their constituent principles.

de·com·po·si·tion
n.
1.
 by activated protein C. (US 6,426,192)
COPYRIGHT 2002 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Pentapharm AG, detecting disorders in protein C system
Comment:Pentapharm obtains United States patent.(Pentapharm AG, detecting disorders in protein C system)
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:4EXSI
Date:Jul 1, 2002
Words:41
Previous Article:United States of America obtains United States patent.(gene, type C Niemann-Pick disease)(Brief Article)
Next Article:United States of America obtains United States patent.(protease-activatable Pseudomonas exotoxin A-like proproteins)(Brief Article)
Topics:



Related Articles
Repligen issued broad United States patent for use of secretin in the treatment of autism.(Brief Article)
Important United States patent secures Pharming's position on human alpha-glucosidase.(Brief Article)
Transkaryotic receives patent for gene targeting technology.
Avigen granted broad hemophilia A gene therapy patent.
Oxford announces grant of expanded high-throughput proteomics patent.(Brief Article)
Transkaryotic awarded patent relating to production and delivery of proteins.(Brief Article)
MorphoSys issued European patent for HuCAL antibody technology.(Brief Article)
Targeted Genetics expands intellectual property.(covering both intramuscular and intravenous routes of delivery of a tumor necrosis factor)
Repligen announces district court decision in inventorship dispute with Bristol-Myers Squibb.
Pharming acquires patent portfolio of PPL therapeutics.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles